2021年6月23日 更新

Russia’s Gamaleya seeks to amend EUA of COVID-19 vaccine

みんなの評価 平均 -(- 件)

あなたの評価

Alexis Romero (Philstar.com) – June 22, 2021 – 8:14pm MANILA, Philippines — Russia’s Gamaleya Institute, the manufacturer of COVID-19 vaccine Sputnik V, wants its emergency use authorization (EUA) amended to lengthen the interval between the two doses of its jab, the Food and Drug Administration (FDA) said. “They (Gamaleya) have already written us to say that they might be amending the emergency use authorization to extend the time interval between the two doses,” FDA director general Eric Domingo said during a meeting of the government’s pandemic task force last Monday. “This is very similar ...

関連する記事 こんな記事も人気です♪

この記事のキュレーター

管理者 管理者

この記事へのコメント

コメントはまだありません

コメントを書く